Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-up

Maximilian Alexander A Rohnert, Malte von Bonin, Michael Kramer, Philipp Ensel, Nadja Holtschke, Christoph Rollig, MD MSC, Martin Bornhäuser, MD, Veit Buecklein, MD, Marion Subklewe, MD, Stefan W Krause, Simon Voelkl, Tobias Berg, Michael A Rieger, Cornelia Brendel, Jörg Hoffmann, Nicole Hofmeister-Mielke, Richard F. Schlenk, Sylvie D Freeman, Uta Oelschlägel

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-138683

Published: 2020

Journal Articles

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

Miriam Frech, PhD, Kathleen Stabla, Andrea Nist, PhD, Marco Mernberger, PhD, Heidi Altmann, PhD, Uwe Platzbecker, Christian Thiede, MD, Prema Erramsetti, Sabine Teichler, PhD, Cornelia Brendel, MD, Richard F. Schlenk, MD, Thorsten Stiewe, MD, Andreas Neubauer, MD

Blood (2018) 132 (Supplement 1): 3902.

https://doi.org/10.1182/blood-2018-99-112978

Published: 2018

Journal Articles

Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib

Ashu Kumari, Cornelia Brendel, Andreas Hochhaus, Andreas Neubauer, Andreas Burchert

Blood (2012) 119 (2): 530–539.

https://doi.org/10.1182/blood-2010-08-303495

Published: 2012

Includes: Supplemental data

Journal Articles

α4 integrin levels on mobilized peripheral blood stem cells predict rapidity of engraftment in patients receiving autologous stem cell transplantation

Bernd Hartz, Thorsten Volkmann, Sebastian Irle, Cordula Loechelt, Andreas Neubauer, Cornelia Brendel

Blood (2011) 118 (8): 2362–2365.

https://doi.org/10.1182/blood-2011-02-331918

Published: 2011

Includes: Supplemental data

Journal Articles

Persisting Chronic Myeloid Leukemia Stem and Progenitor Cells From Patients in Major Molecular Remission Under Imatinib Are Characterized by Low BCR/ABL Expression.

Ashu Kumari, Cornelia Brendel, Thorsten Volkmann, Sonja Tajstra, Andreas Neubauer, Andreas Burchert, MD

Blood (2009) 114 (22): 2207.

https://doi.org/10.1182/blood.V114.22.2207.2207

Published: 2009

Journal Articles

Monitoring of Donor Chimerism in CD34+ Peripheral Blood Progenitors Allows to Detect Minimal Residual Disease after Allogeneic Stem Cell Transplantation -Results of a Randomized Trial

Martin Bornhaeuser, Uta Oelschlaegel, Gesine Bug, Uwe Platzbecker, Karin Lutterbeck, Michael G Kiehl, Johannes Schetelig, Alexander Kiani, Thomas Illmer, Markus Schaich, MD, Catrin Theuser, Brigitte Mohr, Cornelia Brendel, Axel A Fauser, Stefan Klein, Hans Martin, Gerhard Ehninger, MD, Christian Thiede

Blood (2008) 112 (11): 340.

https://doi.org/10.1182/blood.V112.11.340.340

Published: 2008

Journal Articles

Efflux of the Tyrosine Kinase Inhibitors Imatinib and Nilotinib (AMN107) Is Mediated by ABCB1 (MDR1)-Type P-Glycoprotein.

Marius Dohse, Robert W. Robey, Cornelia Brendel, Susan Bates, Andreas Neubauer, Christian Scharenberg

Blood (2006) 108 (11): 1367.

https://doi.org/10.1182/blood.V108.11.1367.1367

Published: 2006

Journal Articles

Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL + progenitors via JAK-2/STAT-5 pathway activation

Ying Wang, Dali Cai, Cornelia Brendel, Christine Barett, Philipp Erben, Paul W. Manley, Andreas Hochhaus, Andreas Neubauer, Andreas Burchert

Blood (2006) 109 (5): 2147–2155.

https://doi.org/10.1182/blood-2006-08-040022

Published: 2006

Includes: Supplemental data

Journal Articles

Adaptive Autocrine Secretion of the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Mediates Imatinib- and Nilotinib-Resistance in BCR/ABL-Positive Progenitors Via JAK-2/STAT-5 Pathway Activation.

Andreas Burchert, Ying Wang, Cornelia Brendel, Philipp Erben, Paul W. Manley, Andreas Hochhaus, Dali Cai, Andreas Neubauer

Blood (2006) 108 (11): 2187.

https://doi.org/10.1182/blood.V108.11.2187.2187

Published: 2006

Journal Articles

Aldehyde Dehydrogenase Expression in Primitive Human Hematopoietic Progenitor Cells with Side Population Characteristic and in Samples from Patients with Acute Myeloid Leukemia.

Ute Meissauer, Joerg Hoffmann, Christian Scharenberg, MD, Andreas Neubauer, MD, Cornelia Brendel, MD

Blood (2005) 106 (11): 4570.

https://doi.org/10.1182/blood.V106.11.4570.4570

Published: 2005

Journal Articles

Hematopoietic Stem Cells Actively Extrude Imatinib-Mesylate Due to High ABCG2-Transporter Activity.

Christian Scharenberg, MD, Michaela Gessner, Joerg Hoffmann, Robert Robey, Andreas Neubauer, MD, Cornelia Brendel, MD

Blood (2005) 106 (11): 1372.

https://doi.org/10.1182/blood.V106.11.1372.1372

Published: 2005

Journal Articles

Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP - neutrophils from NB1 GP–expressing individuals and association of low expression with NB1 gene polymorphisms

Jens Wolff, Cornelia Brendel, Ludger Fink, Rainer M. Bohle, Karin Kissel, Juergen Bux

Blood (2003) 102 (2): 731–733.

https://doi.org/10.1182/blood-2002-09-2831

Published: 2003

Journal Articles

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Andreas Burchert, Stefan Wölfl, Manuel Schmidt, Cornelia Brendel, Barbara Denecke, Dali Cai, Larissa Odyvanova, Tanja Lahaye, Martin C. Müller, Thomas Berg, Harald Gschaidmeier, Burghardt Wittig, Rüdiger Hehlmann, Andreas Hochhaus, Andreas Neubauer

Blood (2003) 101 (1): 259–264.

https://doi.org/10.1182/blood-2002-02-0659

Published: 2003

NARROW

Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-up

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib

α4 integrin levels on mobilized peripheral blood stem cells predict rapidity of engraftment in patients receiving autologous stem cell transplantation

Persisting Chronic Myeloid Leukemia Stem and Progenitor Cells From Patients in Major Molecular Remission Under Imatinib Are Characterized by Low BCR/ABL Expression.

Monitoring of Donor Chimerism in CD34+ Peripheral Blood Progenitors Allows to Detect Minimal Residual Disease after Allogeneic Stem Cell Transplantation -Results of a Randomized Trial

Efflux of the Tyrosine Kinase Inhibitors Imatinib and Nilotinib (AMN107) Is Mediated by ABCB1 (MDR1)-Type P-Glycoprotein.

Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL + progenitors via JAK-2/STAT-5 pathway activation

Adaptive Autocrine Secretion of the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Mediates Imatinib- and Nilotinib-Resistance in BCR/ABL-Positive Progenitors Via JAK-2/STAT-5 Pathway Activation.

Aldehyde Dehydrogenase Expression in Primitive Human Hematopoietic Progenitor Cells with Side Population Characteristic and in Samples from Patients with Acute Myeloid Leukemia.

Hematopoietic Stem Cells Actively Extrude Imatinib-Mesylate Due to High ABCG2-Transporter Activity.

Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP - neutrophils from NB1 GP–expressing individuals and association of low expression with NB1 gene polymorphisms

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only